348 related articles for article (PubMed ID: 26502772)
1. Molecular Cloning, Tissue Distribution, and Functional Characterization of Marmoset Cytochrome P450 1A1, 1A2, and 1B1.
Uehara S; Uno Y; Inoue T; Sasaki E; Yamazaki H
Drug Metab Dispos; 2016 Jan; 44(1):8-15. PubMed ID: 26502772
[TBL] [Abstract][Full Text] [Related]
2. Substrate Selectivities and Catalytic Activities of Marmoset Liver Cytochrome P450 2A6 Differed from Those of Human P450 2A6.
Uehara S; Uno Y; Inoue T; Sasaki E; Yamazaki H
Drug Metab Dispos; 2015 Jul; 43(7):969-76. PubMed ID: 25858611
[TBL] [Abstract][Full Text] [Related]
3. Molecular cloning and functional analysis of cytochrome P450 1A2 from Japanese monkey liver: comparison with marmoset cytochrome P450 1A2.
Narimatsu S; Oda M; Hichiya H; Isobe T; Asaoka K; Hanioka N; Yamano S; Shinoda S; Yamamoto S
Chem Biol Interact; 2005 Feb; 152(1):1-12. PubMed ID: 15766918
[TBL] [Abstract][Full Text] [Related]
4. Marmoset Cytochrome P450 3A4 Ortholog Expressed in Liver and Small-Intestine Tissues Efficiently Metabolizes Midazolam, Alprazolam, Nifedipine, and Testosterone.
Uehara S; Uno Y; Nakanishi K; Ishii S; Inoue T; Sasaki E; Yamazaki H
Drug Metab Dispos; 2017 May; 45(5):457-467. PubMed ID: 28196829
[TBL] [Abstract][Full Text] [Related]
5. A New Marmoset P450 4F12 Enzyme Expressed in Small Intestines and Livers Efficiently Metabolizes Antihistaminic Drug Ebastine.
Uehara S; Uno Y; Yuki Y; Inoue T; Sasaki E; Yamazaki H
Drug Metab Dispos; 2016 Jun; 44(6):833-41. PubMed ID: 27044800
[TBL] [Abstract][Full Text] [Related]
6. Marmoset pulmonary cytochrome P450 2F1 oxidizes biphenyl and 7-ethoxycoumarin and hepatic human P450 substrates.
Uehara S; Uno Y; Oshio T; Inoue T; Sasaki E; Yamazaki H
Xenobiotica; 2018 Jul; 48(7):656-662. PubMed ID: 28689458
[TBL] [Abstract][Full Text] [Related]
7. Marmoset cytochrome P450 2D8 in livers and small intestines metabolizes typical human P450 2D6 substrates, metoprolol, bufuralol and dextromethorphan.
Uehara S; Uno Y; Hagihira Y; Murayama N; Shimizu M; Inoue T; Sasaki E; Yamazaki H
Xenobiotica; 2015; 45(9):766-72. PubMed ID: 25801057
[TBL] [Abstract][Full Text] [Related]
8. Functional characterization and tissue expression of marmoset cytochrome P450 2E1.
Uehara S; Uno Y; Tomioka E; Inoue T; Sasaki E; Yamazaki H
Biopharm Drug Dispos; 2017 Sep; 38(6):394-397. PubMed ID: 28474789
[TBL] [Abstract][Full Text] [Related]
9. Enzymatic characterization of in vitro-expressed Baikal seal cytochrome P450 (CYP) 1A1, 1A2, and 1B1: implication of low metabolic potential of CYP1A2 uniquely evolved in aquatic mammals.
Iwata H; Yamaguchi K; Takeshita Y; Kubota A; Hirakawa S; Isobe T; Hirano M; Kim EY
Aquat Toxicol; 2015 May; 162():138-151. PubMed ID: 25814058
[TBL] [Abstract][Full Text] [Related]
10. Molecular Cloning and Characterization of Marmoset Aldehyde Oxidase.
Uehara S; Uno Y; Okamoto E; Inoue T; Sasaki E; Yamazaki H
Drug Metab Dispos; 2017 Aug; 45(8):883-886. PubMed ID: 28487309
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
Shimada T; Guengerich FP
Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
[TBL] [Abstract][Full Text] [Related]
12. Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.
Shimada T; Murayama N; Okada K; Funae Y; Yamazaki H; Guengerich FP
Chem Res Toxicol; 2007 Mar; 20(3):489-96. PubMed ID: 17291012
[TBL] [Abstract][Full Text] [Related]
13. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol.
Badawi AF; Cavalieri EL; Rogan EG
Metabolism; 2001 Sep; 50(9):1001-3. PubMed ID: 11555828
[TBL] [Abstract][Full Text] [Related]
14. Strong Induction of Cytochrome P450 1A/3A, But not P450 2B, in Cultured Hepatocytes from Common Marmosets and Cynomolgus Monkeys by Typical Human P450 Inducing Agents.
Uehara S; Uno Y; Suzuki T; Inoue T; Utoh M; Sasaki E; Yamazaki H
Drug Metab Lett; 2017; 10(4):244-253. PubMed ID: 27842484
[TBL] [Abstract][Full Text] [Related]
15. Theoretical investigation of differences in nitroreduction of aristolochic acid I by cytochromes P450 1A1, 1A2 and 1B1.
Jerabek P; Martinek V; Stiborova M
Neuro Endocrinol Lett; 2012; 33 Suppl 3():25-32. PubMed ID: 23353840
[TBL] [Abstract][Full Text] [Related]
16. Marmoset cytochrome P450 2B6, a propofol hydroxylase expressed in liver.
Oshio T; Uehara S; Uno Y; Inoue T; Sasaki E; Yamazaki H
Xenobiotica; 2019 Mar; 49(3):265-269. PubMed ID: 29417863
[TBL] [Abstract][Full Text] [Related]
17. Novel Marmoset Cytochrome P450 2C19 in Livers Efficiently Metabolizes Human P450 2C9 and 2C19 Substrates, S-Warfarin, Tolbutamide, Flurbiprofen, and Omeprazole.
Uehara S; Uno Y; Inoue T; Kawano M; Shimizu M; Toda A; Utoh M; Sasaki E; Yamazaki H
Drug Metab Dispos; 2015 Oct; 43(10):1408-16. PubMed ID: 26228688
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization of cytochrome P450 1A1, 1A2, and 1B1, and effects of polychlorinated dibenzo-p-dioxin, dibenzofuran, and biphenyl congeners on their hepatic expression in Baikal seal (Pusa sibirica).
Hirakawa S; Iwata H; Takeshita Y; Kim EY; Sakamoto T; Okajima Y; Amano M; Miyazaki N; Petrov EA; Tanabe S
Toxicol Sci; 2007 Jun; 97(2):318-35. PubMed ID: 17383972
[TBL] [Abstract][Full Text] [Related]
19. Spectral modification and catalytic inhibition of human cytochromes P450 1A1, 1A2, 1B1, 2A6, and 2A13 by four chemopreventive organoselenium compounds.
Shimada T; Murayama N; Tanaka K; Takenaka S; Guengerich FP; Yamazaki H; Komori M
Chem Res Toxicol; 2011 Aug; 24(8):1327-37. PubMed ID: 21732699
[TBL] [Abstract][Full Text] [Related]
20. Effect of chlorinated hydrocarbons on expression of cytochrome P450 1A1, 1A2 and 1B1 and 2- and 4-hydroxylation of 17beta-estradiol in female Sprague-Dawley rats.
Badawi AF; Cavalieri EL; Rogan EG
Carcinogenesis; 2000 Aug; 21(8):1593-9. PubMed ID: 10910964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]